Position in NBIX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$230,731
+$112,938 QoQ
Shares Held
1,369
+53.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#579
of 768 holders
Holding Since
Sep 2022
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026C M BIDWELL & ASSOCIATES LTD holds $588,931 across 7 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (39.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
1,369 | $230,731 | |
| 2 | ALKS |
Alkermes plc.
|
1,981 | $103,804 | |
| 3 | AMRX |
Amneal Pharmaceuticals, Inc.
|
5,415 | $93,733 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,895 | $77,751 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
916 | $75,826 | |
| 6 | LQDA |
Liquidia Corp
|
77 | $6,139 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
225 | $947 |
All Filings in NBIX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $230,731 | 1,369 | Shares | Sole | 2026-08-11 | |
| 2023-12-31 | $117,793 | 894 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $100,012 | 889 | Shares | Sole | 2023-11-13 | |
| 2022-12-31 | $50,045 | 419 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $44,501 | 419 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||